Business
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patientsNEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month. Through LifeMD’s integration with NovoCare® Pharmacy, eligible self-pay and uninsured patients, as wel
About this update from Novo Nordisk A/s Class B
[{"type":"image","alt":"LifeMD, Inc.","displaySize":"","headline":null,"caption":"LifeMD, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/50005343bf87c0ac412a1713ee8f08dc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/61gLXi5OwzzXYAEyNdYSZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/50005343bf87c0ac412a1713ee8f08dc","width":300,"height":300},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/61gLXi5OwzzXYAEyNdYSZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/50005343bf87c0ac412a1713ee8f08dc","width":300,"height":300}},"lazy":false},{"type":"text","content":"Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients","length":84,"tagName":"p"},{"type":"text","content":"NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month. Through LifeMD’s integration with NovoCare® Pharmacy, eligible self-pay and uninsured patients, as well as insured patients whose plans do not cover GLP-1 therapies, now have direct access to all FDA-approved dose strengths of Ozempic® within LifeMD’s end-to-end virtual care platform.","length":599,"tagName":"p"},{"type":"text","content":"LifeMD’s telehealth platform is seamlessly integrated with NovoCare® Pharmacy to provide easy, reliable access to Novo Nordisk’s FDA-approved GLP-1 medications, Ozempic® and Wegovy®, at the most competitive cash-pay price. Patients benefit from a comprehensive care journey that includes:","length":288,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Virtual consultations with LifeMD’s 50-state affiliated medical group,","length":70,"tagName":"p"}]},{"val":[{"type":"text","content":"Ongoing clinical support from licensed providers,","length":49,"tagName":"p"}]},{"val":[{"type":"text","content":"Access to nationwide diagnostic testing,","length":40,"tagName":"p"}]},{"val":[{"type":"text","content":"Pharmacy coordination with fast, reliable shipping and real-time order tracking, and","length":84...